Ignite Creation Date:
2024-05-06 @ 5:37 PM
Last Modification Date:
2024-10-26 @ 2:32 PM
Study NCT ID:
NCT05378425
Status:
RECRUITING
Last Update Posted:
2024-01-29
First Post:
2022-05-12
Brief Title:
A Study of NTX-1088 a Monoclonal Antibody Targeting the Poliovirus Receptor PVR CD155 as Monotherapy and Combined With Pembrolizumab
Sponsor:
Nectin Therapeutics Ltd
Organization:
Nectin Therapeutics Ltd
Organization Data
Organization:
Nectin Therapeutics Ltd
Class:
INDUSTRY
Study ID:
NTX 1088-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nectin Therapeutics Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Merck Sharp Dohme LLC | INDUSTRY |